S
GILD icon

SignatureFD’s Gilead Sciences GILD Stock Holding History

SignatureFD’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.2M Buy
25,292
+154
+0.6% +$20.3K 0.04% 173
2026
Q1 		$3.5M Sell
25,138
-761
-3% -$107K 0.05% 135
2025
Q4 		$3.18M Buy
25,899
+479
+2% +$58.2K 0.05% 148
2025
Q3 		$2.82M Buy
25,420
+808
+3% +$91.8K 0.04% 163
2025
Q2 		$2.73M Buy
24,612
+1,274
+5% +$136K 0.05% 161
2025
Q1 		$2.62M Buy
23,338
+1,276
+6% +$132K 0.05% 148
2024
Q4 		$2.04M Buy
22,062
+1,062
+5% +$95.6K 0.04% 171
2024
Q3 		$1.76M Buy
21,000
+2,271
+12% +$173K 0.03% 200
2024
Q2 		$1.29M Sell
18,729
-3,663
-16% -$244K 0.03% 248
2024
Q1 		$1.64M Sell
22,392
-1,600
-7% -$123K 0.03% 201
2023
Q4 		$1.94M Buy
23,992
+2,249
+10% +$175K 0.04% 156
2023
Q3 		$1.63M Buy
21,743
+118
+0.5% +$9.08K 0.04% 166
2023
Q2 		$1.67M Buy
21,625
+869
+4% +$69.3K 0.04% 154
2023
Q1 		$1.72M Buy
20,756
+1,214
+6% +$101K 0.05% 145
2022
Q4 		$1.68M Buy
19,542
+2,441
+14% +$193K 0.05% 138
2022
Q3 		$1.05M Buy
17,101
+3,784
+28% +$239K 0.04% 184
2022
Q2 		$823K Buy
13,317
+2,289
+21% +$142K 0.03% 236
2022
Q1 		$656K Sell
11,028
-4,048
-27% -$259K 0.02% 317
2021
Q4 		$1.09M Buy
15,076
+175
+1% +$12.1K 0.03% 192
2021
Q3 		$1.04M Buy
14,901
+61
+0.4% +$4.29K 0.04% 192
2021
Q2 		$1.02M Buy
14,840
+2,112
+17% +$141K 0.04% 190
2021
Q1 		$823K Buy
12,728
+1,712
+16% +$110K 0.04% 196
2020
Q4 		$642K Sell
11,016
-579
-5% -$34.9K 0.03% 211
2020
Q3 		$733K Sell
11,595
-2,072
-15% -$144K 0.04% 172
2020
Q2 		$1.05M Buy
13,667
+162
+1% +$12.4K 0.06% 109
2020
Q1 		$1.01M Buy
13,505
+8,567
+173% +$592K 0.09% 94
2019
Q4 		$321K Buy
4,938
+298
+6% +$19.4K 0.02% 338
2019
Q3 		$294K Sell
4,640
-2,484
-35% -$162K 0.02% 313
2019
Q2 		$481K Buy
7,124
+2,098
+42% +$138K 0.04% 184
2019
Q1 		$327K Buy
5,026
+309
+7% +$20.5K 0.03% 253
2018
Q4 		$295K Sell
4,717
-1,613
-25% -$113K 0.03% 261
2018
Q3 		$489K Buy
6,330
+1,110
+21% +$83.8K 0.05% 203
2018
Q2 		$370K Sell
5,220
-1,498
-22% -$106K 0.04% 240
2018
Q1 		$506K Buy
6,718
+928
+16% +$73.8K 0.06% 145
2017
Q4 		$415K Buy
5,790
+95
+2% +$7.21K 0.05% 174
2017
Q3 		$461K Buy
5,695
+851
+18% +$65.1K 0.06% 137
2017
Q2 		$343K Buy
4,844
+247
+5% +$16.4K 0.05% 165
2017
Q1 		$312K Sell
4,597
-5
-0.1% -$352 0.05% 193
2016
Q4 		$330K Buy
4,602
+47
+1% +$3.49K 0.06% 142
2016
Q3 		$360K Buy
4,555
+956
+27% +$77.7K 0.05% 132
2016
Q2 		$300K Sell
3,599
-388
-10% -$34.4K 0.04% 140
2016
Q1 		$366K Buy
3,987
+1,314
+49% +$118K 0.06% 97
2015
Q4 		$270K Sell
2,673
-68
-2% -$7.08K 0.05% 117
2015
Q3 		$269K Buy
2,741
+480
+21% +$53.3K 0.06% 110
2015
Q2 		$265K Sell
2,261
-3,269
-59% -$357K 0.06% 123
2015
Q1 		$543K Sell
5,530
-383
-6% -$38.9K 0.13% 51
2014
Q4 		$557K Buy
5,913
+2,563
+77% +$265K 0.14% 57
2014
Q3 		$357K Sell
3,350
-1,552
-32% -$152K 0.12% 77
2014
Q2 		$406K Buy
4,902
+4,530
+1,218% +$353K 0.14% 58
2014
Q1 		$26K Sell
372
-468
-56% -$36.7K 0.01% 290
2013
Q4 		$63K Buy
840
+400
+91% +$27.9K 0.02% 190
2013
Q3 		$28K Hold
440
– – 0.01% 288
2013
Q2 		$23K Buy
+440
New +$22.9K 0.01% 248

Other funds holding GILD

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
CIM
Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
CGH
Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return

SignatureFD's GILD Position: Q2 2026 in Review

SignatureFD increased its Gilead Sciences (GILD) stake by 0.61% in Q2 2026, buying an estimated $20.3K and bringing the position to 25,292 shares worth $3.2M. The position accounts for 0.04% of the portfolio, ranked #173.

SignatureFD first reported a position in GILD in Q2 2013 and has held it in 53 quarters since. The position peaked at $3.5M in Q1 2026. 690 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • SignatureFD held 25,292 shares of Gilead Sciences worth $3.2M as of Q2 2026.
  • SignatureFD bought 154 Gilead Sciences shares in Q2 2026, an estimated $20.3K.
  • Gilead Sciences made up 0.04% of SignatureFD's portfolio in Q2 2026, its #173 holding.
  • SignatureFD first reported a position in Gilead Sciences in Q2 2013 and has held it in 53 quarters since.
  • SignatureFD's Gilead Sciences position peaked at $3.5M in Q1 2026.
  • 690 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on SignatureFD's 13F filing for Q2 2026, filed 24 Jul 2026.